Use lines 5a(i) and 5a(ii) only. endstream endobj startxref The Repurchase Program is effective immediately and will allow us to reduce dilution and potentially acquire shares at levels that we believe do not reflect the fundamental earnings power of the Company in 2024 and thereafter. With Novavax's unique recombinant nanoparticle technology, the non-infectious spike protein serves as the antigen that primes the immune system to recognize the virus, while Novavax's Matrix-M adjuvant enhances and broadens the immune response. Throughout the year, we executed upon a number of strategic goals and priorities, while successfully mostly completing our merger integration, outperforming our synergy targets, and operating safely and reliably. "I am excited to be joining Novavax at this important time in the company's history," said John C. Jacobs, President and Chief Executive Officer, Novavax. KINETIK HOLDINGS INC.RECONCILIATION OF GAAP TO NON-GAAP MEASURES, Net Income Including Non-controlling Interests to Adjusted EBITDA, Net income (loss) including non-controlling interests (GAAP), Proportionate EBITDA from unconsolidated affiliates, Equity income from unconsolidated affiliates, Cash distributions received from unconsolidated affiliates, Distributions paid to preferred unit limited partners, KINETIK HOLDINGS INC.RECONCILIATION OF GAAP TO NON-GAAP MEASURES (Continued). To access a live webcast of the conference call, please visit the Investor Relations section of Kinetiks website at www.ir.kinetik.com. Beginning in 2022, DHCS will require MCPs to submit a Quarterly Implementation The DE 9C reports individual employee wages for each quarter. You must make Monthly SDI and PIT deposits if either: For assistance, contact our Taxpayer Assistance Center at 1-888-745-3886 or visit your local Employment Tax Office. These risks and uncertainties include, without limitation, challenges satisfying, alone or together with partners, various safety, efficacy, and product characterization requirements, including those related to process qualification and assay validation, necessary to satisfy applicable regulatory authorities; difficulty obtaining scarce raw materials and supplies; resource constraints, including human capital and manufacturing capacity, on the ability of Novavax to pursue planned regulatory pathways; unanticipated challenges or delays in conducting clinical trials; challenges meeting contractual requirements under agreements with multiple commercial, governmental, and other entities; manufacturing delays or challenges, including as a result of the timing of the anticipated regulatory requirements for the fall 2023 vaccination season; the loss of future funding from the U.S. government; the potential for an unfavorable outcome in disputes, including the pending arbitration with Gavi; and those other risk factors identified in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Novavax's Annual Report on Form 10-K for the year ended December 31, 2021 and subsequent Quarterly Reports on Form 10-Q, as filed with the Securities and Exchange Commission (SEC). IFTA filing is due on the last day of the month following the end of each quarter. Please visit novavax.com and LinkedIn for more information. Join other passionately curious people who are bringing innovative vaccines to the world. (5) Net Debt is defined as total long-term debt, excluding deferred financing costs, less cash and cash equivalents. We will also charge a penalty of $20 for each employee, plus interest, if an employer fails to report by magnetic media when required, unless there is good cause. These benefits were partially offset by weaker commodity prices in the fourth quarter and the impact of Winter Storm Elliott, which temporarily resulted in lower gas and crude volumes across the system during the second half of December. Net Debt is defined as total long-term debt, excluding deferred financing costs, less cash and cash equivalents. As the Transaction was determined to be a reverse merger, BCP was considered the accounting acquirer and Altus was considered the legal acquirer. On January 31, 2022, the first quarterly Project and Expenditure Report is due for counties that have certified for Recovery Funds and have either a population that exceeds 250,000 residents or received over $10 million in Recovery Funds. A replay of the conference call will be available starting at 7:30 p.m. [2] Notice that this filing deadline falls on a weekend or federal holiday. Apache, Blackstone, I Squared, and Management (collectively, the Core Shareholders ) have agreed to reinvest 100% of their 2023 dividends 7, which will help fund our capital program while also working towards our long-term 3.5x Leverage Target 2,8. HS]O0}_qd_TILXv]@O.K{=p> X1R)MD*u 7p\y D2a\&bh1hq{.uNj`)9T@*pU&T!Bz $2ToWIGtfN.[4y7n1MDP0j=g*E^ X2SYJsOJ=I!J]D]KRihmOS-f&nR#wa{:f$f? Kinetik plans to participate at the following upcoming conferences and events: An updated investor presentation will be available under Events and Presentations in the Investors section of the Companys website at www.kinetik.com. Distributable Cash Flow should not be considered as an alternative to the GAAP measure of net income including non-controlling interests or any other measure of financial performance presented in accordance with GAAP. DHCS will provide MCPs with the SFTP location. Constructing D Link, Kinetiks owned and operated 30 intrabasin residue gas pipeline to Waha, with an initial throughput capacity of 1 Bcf/d. Novavax will host its quarterly conference call today at 4:30 p.m. TODAY. Novavax has demonstrated its ability to quickly produce viable vaccine candidates for emerging infectious diseases such as COVID-19. Kinetik became the first and only midstream company to link one hundred percent of its debt capital structure to sustainability-related objectives. It is managements intent to provide non-GAAP financial information to enhance understanding of our consolidated financial information as prepared in according with GAAP. Find information and resources about required filings and due dates to help you follow Californias payroll tax laws. endstream endobj 1812 0 obj <>/ProcSet[/PDF/Text]>>/Rotate 0/StructParents 0/Type/Page>> endobj 1813 0 obj <>/ProcSet[/PDF/Text]>>/Subtype/Form/Type/XObject>>stream Reorganized executive leadership team to better align internal resources and operate more efficiently; key changes include: Strengthened Board of Directors with appointment of. Our 2023 Guidance assumes commodity prices for 2023 of approximately $76 per barrel for WTI, $2.07 per MMBtu for natural gas, and $0.69 per gallon for natural gas liquids, all lower year-over-year. You are required to file a Form 1099-MISC for the services performed by the independent contractor. Board approved hedging program in place, de-risking 2023 and 2024 commodity exposure. Any forward-looking statement made by us in this news release speaks only as of the date on which it is made. Results benefited from increased volumes across both the Midstream Logistics and Pipeline Transportation segments as well as over $30 million of Adjusted EBITDA 2 synergies from cost reductions, system optimization, and compression relocation projects. You can find more detailed information to follow in theCalifornia Employers Guide(DE 44) (PDF). Quarter 2 report due 14 February 2023 (reporting period 1 October 2022 31 December 2022) Achieved quarterly net income 1 of $48.5 million and Pro Forma Adjusted EBITDA 2,3,4 of $211.1 million. February 24, 2023 CORRECTING and REPLACING Insulet Reports Full Year 2022 Revenue Increase of 19% (22% constant currency1) and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year (24% constant currency) Download Represents 7th Consecutive Year of 20% or More Constant Currency Revenue Growth The results for Altus are specifically excluded for the period from January 1, 2022 to February 22, 2022. Official websites use .gov For electronic forms, the EDD uses the date they are completed and transmitted to decide if it is on time. Total revenue for the full year 2022 was $1.9 billion and reflects 73% growth compared to $1.1 billion in the same period in 2021. If you have not started accepting applications, please enter N in cell D29 beneath the No, and the estimated date (MM/DD/YYYY) for accepting applications in E29 (use Control + Enter to add information to each cell). The words anticipate, believe, continue, could, estimate, expect, intends, may, might, plan, seeks, possible, potential, predict, project, prospects, guidance, outlook, should, would, will, and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. ), Commission regulations (Title 11 of the Code of Federal Regulations), Commission advisory opinions and applicable court decisions. Record Year for Revenue and Profit Fourth Quarter Results Reflected Revenue Push-Outs due to Scheduling Changes Continued European Expansion Guiding to Increased Adjusted EBITDA in 2023 Reiterating 2024 This information is not intended to replace the law or to change its meaning, nor does this information create or confer any rights for or on any person or bind the Federal Election Commission or the public. You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. (These items are generally listed as separate items on the state's quarterly wage report.) If a tax payment is due, you should submit your payment separately with aPayroll Tax Deposit(DE 88/DE 88ALL). (2) Share amounts have been retrospectively restated to reflect the Companys two-for-one stock split, which was effected on June 8, 2022. While forward-looking statements are based on assumptions and analyses made by us that we believe to be reasonable under the circumstances, whether actual results and developments will meet our expectations and predictions depend on a number of risks and uncertainties which could cause our actual results, performance, and financial condition to differ materially from our expectations. If the DE 9C is not submitted within 15 days of the demand date, we will charge a penalty of $20 for each unreported employee, plusinterest, unless there is good cause for the delay. These data will inform the phase 3 trials for both influenza stand-alone and COVID-19-influenza combination vaccine candidates. Fourth Quarter Financial Highlights: Fourth quarter 2022 revenue of $369.7 million, up 20.1%, or 23.7% in constant currency, compared to $307.7 million in the prior *Included in current and noncurrent liabilities as of December 31, 2022 and non-current liabilities as of, Recombinant protein-based nanoparticle vaccine, Global vaccine authorization / approval map, Diversity matters: Inclusivity in clinical trials, From pandemic to endemic: Why COVID-19 may be here to stay, Standing on the shoulders of giants: How a Novavax vaccine is developed, Recombinant nanoparticle vaccine technology, Global vaccine authorization/approval map, Global authorization site of Novavax COVID-19 Vaccine (recombinant, adjuvanted), Ask medical questions, report adverse events, and product quality complaints, Pay Transparency Nondiscrimination Provision, Delivered over 100 million doses of Nuvaxovid, Novavax's COVID-19 vaccine, globally to date, Modified agreement with the U.S. government for up to 1.5 million additional doses of Novavax's COVID-19 vaccine for delivery in 2023, Agreement maintains the U.S. public's access to Novavax's COVID-19 vaccine and supports the development of smaller dose vials, strain selection in line with U.S. Food and Drug Administration (FDA) recommendations and a smooth transition to the commercial market, Reaffirmed intent to deliver an updated mono- or bivalent strain vaccine for the 2023 fall vaccination season, consistent with public health recommendations, Secured European Medicines Agency (EMA) and FDA approval of Nuvaxovid five-dose vial variation and EMA approval of the Company's, Presented data to the U.S. FDA Vaccine and Related Biological Products Advisory Committee demonstrating that when used as a booster, Novavax's COVID-19 vaccine induces broad functional immune responses, including for contemporary variants, Part 2 to evaluate our prototype vaccine compared to an Omicron BA.5 vaccine, as well as a bivalent containing prototype and Omicron BA.5 vaccine, Expanded Nuvaxovid label in adult booster and adolescent primary series to enable broader uptake in the long-term commercial market, Initiated Phase 2 dose-confirming trial to evaluate safety and immunogenicity of different formulations of CIC and influenza stand-alone vaccine candidates in adults aged 50 to 80 years, with topline results expected by mid-year 2023, CIC Phase 2 trial includes additional study arms exploring alternate influenza stand-alone formulations. You can use e-Services for Business to fulfill thise-file and e-pay mandate. Volumes will be gathered on Kinetiks super-system and processed at Kinetiks existing processing complexes with over 2 Bcf/d of processing capacity. Mandatory EFT filers must send all State Disability Insurance and Personal Income Tax deposits by EFT to avoid penalties. WebFourth quarter 2022 average ROV revenue per day on hire of $8,967 was 6% higher than in the third quarter of 2022. HOUSTON & MIDLAND, Texas--(BUSINESS WIRE)--Feb 27, 2023--. "CYhpEObbG`aH??iQSj*{rfLbEdv va[?UZ.Nna!gI\ ,X]5 Novavax's COVID-19 vaccine is a protein-based vaccine made by creating copies of the surface spike protein of SARS-CoV-2 that causes COVID-19. KINETIK HOLDINGS INC.CONSOLIDATED STATEMENTS OF OPERATIONS(Unaudited), Costs of sales (exclusive of depreciation and amortization shown separately below), Gain on redemption of mandatorily redeemable Preferred Units, Equity in earnings of unconsolidated affiliates, Net income (loss) including non-controlling interest, Net income attributable to Preferred Unit limited partners, Net Income (loss) attributable to common shareholders, Net income (loss) attributable to Common Unit limited partners, Net income attributable to Class A Common Shareholders, Net income attributable to Class A Common Shareholders, per share. Kinetik Reports Fourth Quarter and Full Year 2022 Financial and Operating Results and Provides 2023 Guidance, Download the Globe app to my phone or tablet, Cheryle Finley: Tinned fish a returning trend, Amanda Stone: Papaya a decent shopping discovery, Anniversary memorial services planned for 2 sla, https://www.businesswire.com/news/home/20230227005881/en/. Total revenue for the fourth quarter 2022 was $357 million and reflects 61% growth compared to $222 million in the same period in 2021. Credit and finance for MSMEs: As of December 31, 2022, portfolio at risk (PAR) 180+ days past due (dpd) deteriorated to 11.49 per cent from 11.02 per cent in Q2. A reconciliation of expected full year or annualized December 2023 Adjusted EBITDA to net income (loss), the closest GAAP financial measure, cannot be provided without unreasonable efforts due to the inherent difficulty in quantifying certain amounts, including share-based compensation expense, which is affected by factors including future personnel needs and the future prices of our Class A Common Stock, which may be significant. Reduced Kinetiks floating interest rate exposure as a percentage of total current debt outstanding to less than 15% through April 2023 and approximately 40% thereafter. 4+t?1zxn nmZn5&xUAX5N(;a,r}=YUUA?z r[ $ This news release contains statements from certain Core Shareholders regarding future plans and expectations. Notes Regarding Presentation of Financial Information, For US GAAP purposes, Kinetiks financial results reflect BCP Raptor Holdco, LP, Kinetiks predecessor for accounting purposes (BCP), from January 1, 2022 to February 22, 2022 and the combined Company, which includes Altus Midstream LP (Altus), from the closing date, February 22, 2022, onwards. We reported full year 2022 Pro Forma Adjusted EBITDA 2,3,4 of $822.2 million, meeting the revised guidance we provided in August (and exceeding the top end of the initial guidance we issued at the start of the year), despite lower commodity prices in the second half of 2022, and the impact of Decembers Winter Storm Elliott. Earnings Per Share and Diluted Adjusted Earnings Per Share. Pro forma information has been prepared for informational purposes only. Low Income Household Water Assistance Program, AT#: LIHWAP-AT-2022-03, DATE: March 29, 2022, TO: Low Income Household Water Assistance Program (LIHWAP) Grant Recipients, SUBJECT: LIHWAP Quarter 2 Report Submission, ATTACHMENT(S): LIHWAP Quarterly Report Instructions(PDF). Share sensitive information only on official, secure websites. (1) The results of the legacy Altus business are not included in the Companys consolidated financials prior to February 22, 2022. FY22 Q1 Quarterly Report Due Date. View due dates and actions for each month. Director, Division of Energy Assistance Find elections. The FY22 Q2 Quarterly Report covering January 1, 2022 through March 31, 2022 is due April 29, 2022 at 5PM EST. 0qPWp:dW5 ;6V]BpJ#@DE"?Fo=+57]>>=@^{"p5yM~'A}t`)6ts(T^ `p]~@5zPn/VO=RB;#Gkj@!bg~7s}f (Usually due October 15, which falls on a weekend in 2022.) If Dec. 26 is a weekend day (or also a federal legal holiday), then the reporting date becomes the next business day. Novavax cautions that these forward-looking statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. QUARTERLY FIGURES YESTERDAY. If a checkbox does not appear please complete the following steps to complete your reply: Quarterly reports provide critical information on the status of program implementation. See Notes Regarding Presentation of Financial Information and Reconciliation of Pro Forma Non-GAAP Measures.. Core shareholders to reinvest 100% of dividends from base shares held at closing date of merger. The forward-looking statements in this press release speak only as of the date of this document, and we undertake no obligation to update or revise any of the statements. Electronic Data Interchange (EDI): This one time report will cover the time period from January 1, 2022, through March 1, 2022, and will be due to DHCS on May 15, 2022. Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to protect against serious infectious diseases. As a result, our 2023 Guidance does not include the $70 million of commodity price benefits that we realized in 2022. Revenues for the fourth quarter of 2022 were $142.5 million, an increase of $24.0 million compared to the fourth quarter of 2021. Therefore, BCPs net assets, carrying at historical value, were presented as the predecessor to the Companys historical financial statements and the comparable period presented herein reflects the results of operations of BCP for the three and twelve months ended December 31, 2021. Grant recipients should email their quarterly report toLIHWAPreports@acf.hhs.gov. 1807 0 obj <> endobj Reported full year 2022 Capital Expenditures 5 of $284.0 million, within the Companys revised guidance range provided in August, and for the fourth quarter 2022 reported Capital Expenditures 5 of $68.3 million. Participants will be prompted to request to join the Novavax, Inc. call. The increase was mainly due to revenues on our recently acquired Sinclair Transportation assets, higher volumes on our crude and product pipelines, and rate increases that went into effect on July 1, 2022. We made great strides towards our capital structure goals by fully redeeming the Series A Preferred Units and completing our comprehensive refinancing. WebInvestor Relations > Financial Reports > Quarterly Earnings > 2022. print-link mail-link. (2) Adjusted EBITDA is defined as net income including non-controlling interests adjusted for interest, taxes, depreciation and amortization, impairment charges, the proportionate EBITDA from unconsolidated affiliates, equity in earnings from unconsolidated affiliates, stock-based compensation expense, extraordinary losses and other unusual or non-recurring charges. Additional context on Kinetiks sustainability strategy, targets, and results for fiscal year 2022 will be detailed in its 2022 ESG Report, expected to be published mid-year. Payroll Tax Deposit (DE 88) is used to report and pay Unemployment Insurance (UI), Employment Training Tax (ETT), State Disability Insurance (SDI) withholding, and California Personal Income Tax (PIT) withholding to us. A reporting period always begins the day after the closing date of the last report filed. Nio has surpassed analysts sales forecast in the past 12 months. For 2023, Kinetik has identified several strategies to progress its greenhouse gas and methane emission-related reduction goals through the application of technologies, best practices, increased training, and greater partnerships with key suppliers into emissions reduction. In December 2022, 3M announced it will exit per- and polyfluoroalkyl substance (PFAS) manufacturing by the end of 2025. Washington, DC 20463, Federal Election Commission | United States of America, October Quarterly Report notice for congressional committees, PACs and parties (2022). Granting 2022 performance bonuses to Executive Officers in Kinetik Class A Common Stock rather than cash. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS, (in thousands, except per share information). The Midstream Logistics Capital Expenditures primarily relate to the build-out of over 20 miles of new, large diameter, high-pressure pipeline north from the existing Kinetik gathering system into Lea County, New Mexico and gathering and compression projects for existing customers new wells connected to the system. Kinetik Holdings Inc. (NYSE: KNTK) ( Kinetik or the Company ) today reported financial results for the quarter and year ended December 31, 2022. Weekend due dates may be postmarked the following business day. (1) The results of the legacy Altus business are not included in the Companys consolidated financials prior to February 22, 2022. Read supplemental filing information [congressional committees] [PACs and parties]. Net Debt illustrates our total debt position less cash on hand that could be utilized to pay down debt at the balance sheet date. You are a Next-Day or Semiweekly depositor and you accumulate $350-$500 in PIT during one or more pay periods. Heres how you know Novavax creates transformational vaccines that help address some of the worlds most pressing infectious diseases. If the committee is new and has not previously filed a report, the first report As with the Q1 report, the signature may be typed directly into the document and does not need to be an official e-signature. Self-insured employers must file by mail. If you are required to file a federal Form 1099-MISC, you must report specific information to us. A reporting period always begins the day after the closing date of the last report filed. The Company plans for a similar approach in 2023. If you have an approvedE-file and E-pay Mandate Waiver Request(DE 1245W), your tax forms and Payroll Tax Deposit (DE 88ALL) coupons will be mailed to you automatically. The results of operations of Altus are reflected within the Companys Consolidated Financial Statements from February 22, 2022, the closing date, through December 31, 2022.
Grand Valley State Basketball Roster,
Steuben County Surplus Auction 2021,
Hgtv Home Town Lawsuit,
Close Funeral Home Bainbridge, Ga Obituaries,
Michael Wooley Shreveport, Louisiana,
Articles W